Key result
Lack of PKC-α in mice treated with ANG II led to increased urine output, decreased AQP2 abundance, and decreased CREB phosphorylation compared to wild-type mice.
In a mouse model of ANG II-induced hypertension, PKC-α is essential for maintaining urine concentrating ability and AQP2 levels via CREB phosphorylation.
No clinical implications yet; leaves open PKC-α as regulator of AQP2 in human hypertension.
Regulation of water and urea transport in the inner medullary collecting duct is essential for urine concentration. Aquaporin (AQP)2 water channels and urea transporter (UT)-A1 are inserted into the apical membrane upon phosphorylation of the channels to allow the transcellular movement of water and urea. Since ANG II activates PKC in many cell types, we tested the hypothesis that ANG II-induced regulation of water and urea transport is mediated by PKC. Osmotic minipumps delivered ANG II to wild-type (WT) or PKC-α(-/-) mice for 7 days. Inner medullas were harvested, and protein abundance was determined by immunoblot. ANG II increased systolic blood pressure to a similar degree in WT and PKC-α(-/-) mice. ANG II had no effect on the urine output of WT mice but increased that of PKC-α(-/-) mice. In accordance with observed differences in urine output, AQP2 abundance was unchanged in ANG II-treated WT animals but was decreased in PKC-α(-/-) mice. No change in membrane accumulation was seen. Phosphorylation of the cAMP-induced transcription factor CREB was decreased in PKC-α(-/-) mice in response to ANG II with no change in overall CREB abundance. ANG II did not alter the abundance of UT-A1 protein in WT or PKC-α(-/-) mice. Phosphorylation and overall abundance of tonicity-responsive enhancer-binding protein, a transcription factor that regulates UT-A1, were also unaltered by ANG II in either group. We conclude that PKC-α protects against ANG II-induced decreases in urine concentrating ability by maintaining AQP2 levels through CREB phosphorylation.
No takes yet. Share an insight, caveat, or question.
Thai et al. (2012) studied Angiotensin II-induced hypertension. Angiotensin II (ANG II) vs. Wild-type vs PKC-α(-/-) mice was evaluated on Urine output, AQP2 abundance, and CREB phosphorylation. Lack of PKC-α in mice treated with ANG II led to increased urine output, decreased AQP2 abundance, and decreased CREB phosphorylation compared to wild-type mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: